LGVN
Longeveron Inc - Ordinary Shares - Class A

13,115
Loading...
Loading...
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
26

Frequently Asked Questions

What is Market Cap of Longeveron Inc - Ordinary Shares - Class A?
What is the 52-week high for Longeveron Inc - Ordinary Shares - Class A?
What is the 52-week low for Longeveron Inc - Ordinary Shares - Class A?
What is Longeveron Inc - Ordinary Shares - Class A stock price today?
What was Longeveron Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Longeveron Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Longeveron Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Longeveron Inc - Ordinary Shares - Class A?
How many employess does Longeveron Inc - Ordinary Shares - Class A has?

Latest LGVN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.